/3034.T

3034.T Stock - Qol Holdings Co., Ltd.

Q: What is the analyst price target for 3034.T?

Analyst price target information is not currently available for 3034.T.

Q: What is 3034.T's market cap?

Market capitalization information is not currently available for 3034.T.

Healthcare|Medical - Pharmaceuticals|JPX

$2223.00+0.95%

+$21.00 (+0.95%) • Dec 23

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $2445.30

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for 3034.T

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.03

52W High$2404.00

52W Low$1399.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$263.97B	$180.05B	$170.04B	$166.20B	$161.83B
Gross Profit	$34.73B	$23.25B	$23.50B	$23.16B	$21.10B
Gross Margin	13.2%	12.9%	13.8%	13.9%	13.0%
Operating Income	$13.46B	$8.32B	$9.49B	$9.86B	$7.36B
Net Income	$5.16B	$4.88B	$5.66B	$5.49B	$3.37B
Net Margin	2.0%	2.7%	3.3%	3.3%	2.1%
EPS	$137.95	$131.10	$152.95	$149.49	$89.53

Company Overview

Qol Holdings Co., Ltd., together with its subsidiaries, engages in dispensing pharmacy and business process outsourcing contracting businesses in Japan. The company operates dispensing pharmacies through one-on-one store opening based on one-on-one trust relationships with medical institutions. It also undertakes sales and marketing research activities for pharmaceutical companies; and provides temporary staff dispatch for pharmacists, nurses, registered sellers, registered dietitians, etc. In addition, the company offers clinical trial support services for pharmaceuticals and food products; support, monitoring, and technician dispatch services of managers for various processes, from planning of trial execution plans to monitoring, secretariat support, statistical analysis, and the presentation of conference papers; and publishing related services. The company was formerly known as Qol Co., Ltd. and changed its name to Qol Holdings Co., Ltd. in October 2018. Qol Holdings Co., Ltd. was founded in 1992 and is headquartered in Tokyo, Japan.

Visit Website

Earnings History & Surprises

3034.T

Beat Rate

27%

Last 11 quarters

Avg Surprise

+4.9%

EPS vs Estimate

Beats / Misses

3/8

Last 12 quarters

Latest EPS

$45.04

Q4 2025

EPS Surprise History

Q4 23

No data

Q1 24

No data

Q2 24

No data

Q3 24

No data

Q4 24

No data

Q1 25

No data

Q2 25

No data

Q4 25

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q4 2025	Nov 7, 2025	—	$45.04	—	—
Q2 2025	May 9, 2025	—	$43.70	—	—
Q1 2025	Feb 7, 2025	—	$61.75	—	—
Q4 2024	Nov 1, 2024	—	$9.84	—	—
Q3 2024	Aug 2, 2024	—	$22.58	—	—
Q2 2024	May 10, 2024	—	$29.65	—	—
Q1 2024	Feb 2, 2024	—	$50.64	—	—
Q4 2023	Nov 2, 2023	—	$23.60	—	—
Q3 2023	Aug 4, 2023	—	$27.19	—	—
Q2 2023	May 11, 2023	$31.57	$40.39	+27.9%	✓ BEAT
Q1 2023	Feb 3, 2023	$51.45	$48.42	-5.9%	✗ MISS
Q4 2022	Nov 4, 2022	$46.85	$36.94	-21.2%	✗ MISS
Q3 2022	Aug 5, 2022	$36.60	$27.15	-25.8%	✗ MISS
Q2 2022	May 13, 2022	$41.47	$36.25	-12.6%	✗ MISS
Q1 2022	Feb 4, 2022	$66.32	$46.28	-30.2%	✗ MISS
Q4 2021	Nov 5, 2021	$39.30	$38.75	-1.4%	✗ MISS
Q3 2021	Aug 6, 2021	$11.27	$28.21	+150.3%	✓ BEAT
Q2 2021	May 14, 2021	$39.23	$31.00	-21.0%	✗ MISS
Q1 2021	Feb 3, 2021	$29.68	$41.80	+40.8%	✓ BEAT
Q4 2020	Oct 29, 2020	$20.66	$10.81	-47.7%	✗ MISS

Frequently Asked Questions about 3034.T

What is 3034.T's current stock price?

Qol Holdings Co., Ltd. (3034.T) is currently trading at $2223.00 per share. The stock has moved +0.95% today.

What is the analyst price target for 3034.T?

No analyst price targets are currently available for this stock.

What sector is Qol Holdings Co., Ltd. in?

Qol Holdings Co., Ltd. operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the JPX exchange.

What is 3034.T's market cap?

Qol Holdings Co., Ltd. has a market capitalization of $83.40 billion, making it a large-cap company.

Does 3034.T pay dividends?

No, Qol Holdings Co., Ltd. does not currently pay a dividend to shareholders.